Second trimester ultrasound prenasal thickness combined with nasal bone length: A new method of Down syndrome screening

Prenatal Diagnosis

Volumn 25, Issue 10, 2005, Pages 906-911

  Maymon, Ron ^a,c   Levinsohn Tavor, Orna ^a   Cuckle, Howard ^b   Tovbin, Yosef ^a   Dreazen, Eli ^a   Wiener, Yifat ^a   Herman, Arie ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Down syndrome; Nasal bone; Prenasal thickness; Screening; Ultrasound

Indexed keywords

ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOWN SYNDROME; EQUIPMENT; FACIAL BONE; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; KARYOTYPE; MEASUREMENT; NORMAL DISTRIBUTION; PREGNANCY; PRENASAL THICKNESS; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY; ULTRASOUND;

DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; NASAL BONE; NOSE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REGRESSION ANALYSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 27144436854     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1207     Document Type: Article

References (29)

1. Benacerraf BR, Gelman R, Frigoletto FD Jr. 1987. Sonographic identification of second -trimester fetuses with Down's syndrome. N Engl J Med 317: 1371-1376.
2. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. 2002. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 100: 1168-1176.
3. Bromley B, Lieberman E, Shipp TD, Benacerraf BR. 2002. Fetal nose bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 21: 1387-1394.
4. Bunduki V, Ruano R, Miguelez J, Yoshizaki CT, Kahhale S, Zugaib M. 2003. Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21. Ultrasound Obstet Gynecol 21: 156-160.
5. Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides KH. 2004. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan. Ultrasound Obstet Gynecol 23: 218-223.
6. Cicero S, Sonek JD, McKenna DS, Croom CS, Johns L, Nicolaides KH. 2003. Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol 21: 15-18.
7. Cuckle H, Arbuzova S. 2004. Multianalyte maternal serum screening for chromosomal defects. In Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment (5th edn), Milunsky A (ed) USA: Johns Hopkins University Press; 795-835.
8. Cuckle H, Aitken D, Spencer K, Senior B, Standing S, Goodburn S. 2004. Age-standardization for monitoring performance in Down's syndrome screening programmes. Prenat Diagn 24(11): 851-856.
9. Down JLH. 1866. Observations on an ethnic classification of idiots. Clinical lectures and report. London Hospitals 3: 259-262.
10. Gamez F, Ferreiro P, Salmean JM. 2004. Ultrasonographic measurement of fetal nasal bone in a low risk population at 19-22 gestational weeks. Ultrasound Obstet Gynecol 23: 152-153.
11. Goldstein I, Tamir A, Itskovitz-Eldor J, Zimmer EZ. 1997. Growth of the fetal nose width and nostril distance in normal pregnancies. Ultrasound Obstet Gynecol 9: 35-38.
12. Guis F, Ville Y, Vincent Y, Doumerc S, Pons JC, Frydman R. 1995. Ultrasound evaluation of the fetal nasal bone throughout gestation. Ultrasound Obstet Gynecol 5: 304-307.
13. Herman A, Maymon R, Dreazen E, Caspi I, Bukovsky I, Weinraub Z. 1998. Image magnification does not contribute to the repeatability of caliper placement in measuring nuchal translucency thickness. Ultrasound Obstet Gynecol 11: 266-270.
14. Maymon R, Tovbin Y, Dreazen E, Weinraub Z, Herman A. 2004. All five digits of the hands of fetuses with Down syndrome measured are short. Ultrasound Obstet Gynecol 23: 557-560.
15. Perni SC, Chervenak FA, Kalish RB, et al. 2004. Intraobserver and interobserver reproducibility of fetal biometry. Ultrasound Obstet Gynecol 24: 654-658.
16. Pinette MG, Blackstone J, Pan Y, Pinette SG. 1997. Measurement of fetal nasal width by ultrasonography. Am J Obstet Gyncol 179: 842-845.
17. Royston P, Thompson SG. 1992. Model-based screening by risk with application to Down's syndrome. Stats Med 11: 257-268.
18. Rudnicka AR, Wald NJ. 2003. Choice between using delta-NT or NT MoM. Ultrasound Obstet Gynecol 22: 659.
19. Snijders RJM, Noble PL, Sebire NJ, Souka A, Nicolaides KH. 1998. UK multicenter project on assessment of risk of trisomy 21 by maternal age and nuchal translucency thickness at 10-14 weeks of gestation. Lancet 352: 343-346.
20. Sonek JD, Cicero S. 2004. Ultrasound evaluation of the fetal nasal bone: the technique (an update). Down's Screen News 11: 25-27.
21. Sonek JD, McKenna D, Webb D, Croom C, Nicolaides K. 2003. Nasal bone length throughout gestation: normal ranges based on 3537 fetal ultrasound measurements. Ultrasound Obstet Gynecol 21: 152-155.
22. Spencer K, Bindra R, Nix AB, Heath V, Nicolaides KH. 2003. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester. Ultrasound Obstet Gynecol 22: 142-148.
23. Tovbin J, Maymon R, Tovbin L, Dreazen E, Bukovsky I, Herman A. 2002. Prenatal age-specific reference intervals for measuring all five digits of the fetal hand. Ultrasound Obstet Gynecol 19: 583-587.
24. Vintzileos A, Walters C, Yeo L. 2003. Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk population. Obstet Gynecol 101: 905-908.
25. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. 1998a. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol 197: 105-124.
26. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. 1998b. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 91: 319-323.
27. Wald N, Rodeck A, Hackshaw A, Walters J, Chitty L, Mackinson A. 2003. First and second trimester antenatal screening for Down's syndrome. The results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10: 56-104.
28. Weill D, Mattel M-G, Passage E, et al. 1988. Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. Am J Human Genet 43: 435-455.
29. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. 2004. Contingent screening for down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 24: 762-766.